<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04191369</url>
  </required_header>
  <id_info>
    <org_study_id>EUS-EGD-PH</org_study_id>
    <nct_id>NCT04191369</nct_id>
  </id_info>
  <brief_title>EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.</brief_title>
  <official_title>A Randomized Controlled Trial Comparing Endoscopic Ultrasound Evaluation Versus Esophagogastroduodenoscopy in the Diagnosis of Portal Hypertension in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Ecuatoriano de Enfermedades Digestivas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Ecuatoriano de Enfermedades Digestivas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver cirrhosis with the further development of portal hypertension implies structural and
      vasculature alteration in the portosplenic circulation.

      Esophagogastroduodenoscopy is the standard of care for the detection and treatment of
      esophageal varices, as esophageal varices serve as a surrogate for estimating a portal
      pressure gradient &gt; 10 mmHG.

      Endoscopic ultrasound evaluation allows the detection of peri-esophageal collateral veins,
      perforating veins and para-esophageal collateral veins, which has demonstrated to be
      effective for the prediction of esophageal varices recurrence after variceal eradication.

      The investigators aimed to compare esophagogastroduodenoscopy versus endoscopic ultrasound
      evaluation for the early diagnosis of portal hypertension in cirrhotic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized control trial of 70 cirrhotic patients randomly submitted for
      esophagogastroduodenoscopy (35 patients) or EUS evaluation (35 patients) for the diagnosis of
      portal hypertension.

      The portal pressure gradient will be defined based on portal vein catheterization via
      interventional radiology.

      Esophagogastroduodenoscopy will evaluate the presence and grade of esophageal varices,
      presence and type of gastric varices, presence and signs of hypertensive gastropathy.

      Endoscopic ultrasound will evaluate the presence of esophageal varices, the presence of
      gastric varices and the EUS- signs og hypertensive gastropathy, Azygos vein diameter, mean
      velocity and blood flow volume index.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of portal hypertension</measure>
    <time_frame>During portal pressure gradient meassurement up to 4 weeks after randomization</time_frame>
    <description>Portal hypertension diagnosis based on portal pressure gradient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diagnostic accuracy of esophagogastroduodenoscopy</measure>
    <time_frame>during esophagogastroduodenoscopy procedure up to 2 weeks after randomization</time_frame>
    <description>Overall accuracy of esophagogastroduodenoscopy in the detection and grading of esophageal varices, gastric varices and hypertensive gastropathy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diagnostic accuracy of endoscopic ultrasound</measure>
    <time_frame>during endoscopic ultrasound evaluation up yo 2 weeks after randomization</time_frame>
    <description>Overall accuracy of endoscopc ultrasound evaluation in the detection and grading of esophageal varices, gastric varices and hypertensive gastropathy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Liver Cirrhoses</condition>
  <condition>Portal Hypertension</condition>
  <arm_group>
    <arm_group_label>EGD evaluation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Esophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EUS evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI.
Portal pressure gradient will be evaluated via interventional radiology as gold standard.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Esophagogastroduodenoscopy</intervention_name>
    <description>Esophogagastroduodenoscopy for the evaluation of esophageal varices, gastric varices and hypertensive gastropathy. Portal pressure gradient will be evaluated via interventional radiology as gold standard.</description>
    <arm_group_label>EGD evaluation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endoscopic ultrasound</intervention_name>
    <description>Endoscopic ultrasound evaluation for the presence of esophageal varices, peri and para-esophageal collateral veins, gastric varices, portal hypertensive gastropathy, azygos vein diameter, blood flow and BFVI.
Portal pressure gradient will be evaluated via interventional radiology as gold standard.</description>
    <arm_group_label>EUS evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Above 18 years old

          -  Willingness to participate in the study

          -  Compensated liver cirrhosis based on clinical and imaging findings

          -  Written informed consent provided

        Exclusion Criteria:

          -  Decompensated liver cirrhosis: ascitis, encephalopathy, gastrointestinal bleeding,
             infection

          -  Hemodynamic instability

          -  Pregant or nursing patients

          -  Patients with history of esophageal, gastric, liver, pancreas and spleen tumors

          -  Severe uncontrolled coagulopathy

          -  Any contraindication for portal pressure gradient meassurement via radiological
             evaluation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ecuadorian Institute of Digestive Diseases</name>
      <address>
        <city>Guayaquil</city>
        <state>Guayas</state>
        <zip>090505</zip>
        <country>Ecuador</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos A Robles-Medranda, MD</last_name>
      <phone>+593989158865</phone>
      <email>carlosoakm@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Carlos A Robles-Medranda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto A Oleas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ecuador</country>
  </location_countries>
  <reference>
    <citation>Boustière C, Dumas O, Jouffre C, Letard JC, Patouillard B, Etaix JP, Barthélémy C, Audigier JC. Endoscopic ultrasonography classification of gastric varices in patients with cirrhosis. Comparison with endoscopic findings. J Hepatol. 1993 Sep;19(2):268-72.</citation>
    <PMID>8301060</PMID>
  </reference>
  <reference>
    <citation>Hammoud GM, Ibdah JA. Utility of endoscopic ultrasound in patients with portal hypertension. World J Gastroenterol. 2014 Oct 21;20(39):14230-6. doi: 10.3748/wjg.v20.i39.14230. Review.</citation>
    <PMID>25339809</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

